Found: 81
Select item for more details and to access through your institution.
A miRNA Panel Predicts Sensitivity of FGFR Inhibitor in Lung Cancer Cell Lines.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Impact of Clinicopathologic Features on the Efficacy of PD-1/PD-L1 Inhibitors in Patients With Previously Treated Non-small-cell Lung Cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Combination Strategies on the Basis of Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer: Where Do We Stand?
- Published in:
- 2018
- By:
- Publication type:
- journal article
Clinical Characteristics of Pregnant Women With Coronavirus Disease 2019 in Wuhan, China.
- Published in:
- Open Forum Infectious Diseases, 2020, v. 7, n. 8, p. 1, doi. 10.1093/ofid/ofaa294
- By:
- Publication type:
- Article
Tumor neoantigens: from basic research to clinical applications.
- Published in:
- Journal of Hematology & Oncology, 2019, v. 12, n. 1, p. N.PAG, doi. 10.1186/s13045-019-0787-5
- By:
- Publication type:
- Article
Genomic landscape and its correlations with tumor mutational burden, PD-L1 expression, and immune cells infiltration in Chinese lung squamous cell carcinoma.
- Published in:
- Journal of Hematology & Oncology, 2019, v. 12, n. 1, p. N.PAG, doi. 10.1186/s13045-019-0762-1
- By:
- Publication type:
- Article
Novel antibodies against GPIbα inhibit pulmonary metastasis by affecting vWF-GPIbα interaction.
- Published in:
- Journal of Hematology & Oncology, 2018, v. 11, n. 1, p. N.PAG, doi. 10.1186/s13045-018-0659-4
- By:
- Publication type:
- Article
Association of XRCC3 and XPD751 SNP with efficacy of platinum-based chemotherapy in advanced NSCLC patients.
- Published in:
- Clinical & Translational Oncology, 2012, v. 14, n. 3, p. 207, doi. 10.1007/s12094-012-0785-3
- By:
- Publication type:
- Article
Outcomes of Pemetrexed-based chemotherapies in HER2-mutant lung cancers.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Comprehensive evaluation of NT5E/CD73 expression and its prognostic significance in distinct types of cancers.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Multi-cancer blood testing combined with PET-CT: road for hope to screen for cancer and guide intervention.
- Published in:
- Signal Transduction & Targeted Therapy, 2020, v. 5, n. 1, p. 1, doi. 10.1038/s41392-020-0210-2
- By:
- Publication type:
- Article
Designing highly multiplex PCR primer sets with Simulated Annealing Design using Dimer Likelihood Estimation (SADDLE).
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-29500-4
- By:
- Publication type:
- Article
Chinese Experts Consensus on Immune Checkpoint Inhibitors for Non-small Cell Lung Cancer (2020 Version).
- Published in:
- Chinese Journal of Lung Cancer, 2021, v. 24, n. 4, p. 217, doi. 10.3779/j.issn.1009-3419.2021.101.13
- By:
- Publication type:
- Article
Chinese Experts Consensus on Immune Checkpoint Inhibitors for Non-small Cell Lung Cancer (2019 version).
- Published in:
- Chinese Journal of Lung Cancer, 2020, v. 23, n. 2, p. 65, doi. 10.3779/j.issn.1009-3419.2020.02.01
- By:
- Publication type:
- Article
Novel Immuno-oncology Therapy: Current Status of Clinical Research and Prospect of Application.
- Published in:
- Chinese Journal of Lung Cancer, 2017, v. 20, n. 9, p. 645, doi. 10.3779/j.issn.1009-3419.2017.09.10
- By:
- Publication type:
- Article
Four Cases of Interstitial Lung Disease Induced by Erlotinib and A Review of the Literatures.
- Published in:
- Chinese Journal of Lung Cancer, 2012, v. 15, n. 8, p. 494, doi. 10.3779/j.issn.1009-3419.2012.08.08
- By:
- Publication type:
- Article
Front-line treatment for advanced non-small-cell lung cancer and ALK fusion: a network meta-analysis.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221116607
- By:
- Publication type:
- Article
Prognostic value of cyclooxygenase-2 gene polymorphisms in advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapy.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2016, v. 12, n. 2, p. e339, doi. 10.1111/ajco.12258
- By:
- Publication type:
- Article
A Case Report of Chemo-sensitive Intimal Pulmonary Artery Sarcoma.
- Published in:
- Cell Biochemistry & Biophysics, 2014, v. 68, n. 1, p. 153, doi. 10.1007/s12013-013-9681-x
- By:
- Publication type:
- Article
Analysis of Driver Mutations in Female Non-Smoker Asian Patients with Pulmonary Adenocarcinoma.
- Published in:
- Cell Biochemistry & Biophysics, 2012, v. 64, n. 2, p. 155, doi. 10.1007/s12013-012-9384-8
- By:
- Publication type:
- Article
Dynamic Monitoring and Predictive Value of Circulating Tumor Cells in EGFR-Mutated Advanced Non-Small-Cell Lung Cancer Patients Treated With First-Line EGFR Tyrosine Kinase Inhibitors.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A Phase II Clinical Trial of Apatinib in Pretreated Advanced Non-squamous Non-small-cell Lung Cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Heterogeneity of PD-L1 Expression Among the Different Histological Components and Metastatic Lymph Nodes in Patients With Resected Lung Adenosquamous Carcinoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Characterization of Liver Metastasis and Its Effect on Targeted Therapy in EGFR-mutant NSCLC: A Multicenter Study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Effect of Combined Therapy Inhibiting EGFR and VEGFR Pathways in Non--Small-cell Lung Cancer on Progression-free and Overall Survival.
- Published in:
- Clinical Lung Cancer, 2017, v. 18, n. 4, p. 421, doi. 10.1016/j.cllc.2016.12.012
- By:
- Publication type:
- Article
Effect of Combined Therapy Inhibiting EGFR and VEGFR Pathways in Non-Small-cell Lung Cancer on Progression-free and Overall Survival.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Bisphosphonates enhance antitumor effect of EGFR-TKIs in patients with advanced EGFR mutant NSCLC and bone metastases.
- Published in:
- Scientific Reports, 2017, p. 42979, doi. 10.1038/srep42979
- By:
- Publication type:
- Article
Serum Levels of the Cancer-Testis Antigen POTEE and Its Clinical Significance in Non-Small-Cell Lung Cancer.
- Published in:
- PLoS ONE, 2015, v. 10, n. 4, p. 1, doi. 10.1371/journal.pone.0122792
- By:
- Publication type:
- Article
EBUS-TBNA Provides Highest RNA Yield for Multiple Biomarker Testing from Routinely Obtained Small Biopsies in Non-Small Cell Lung Cancer Patients - A Comparative Study of Three Different Minimal Invasive Sampling Methods.
- Published in:
- PLoS ONE, 2013, v. 8, n. 10, p. 1, doi. 10.1371/journal.pone.0077948
- By:
- Publication type:
- Article
The Association between COX-2 Polymorphisms and Hematologic Toxicity in Patients with Advanced Non-Small-Cell Lung Cancer Treated with Platinum-Based Chemotherapy.
- Published in:
- PLoS ONE, 2013, v. 8, n. 4, p. 1, doi. 10.1371/journal.pone.0061585
- By:
- Publication type:
- Article
Association between Single Nucleotide Polymorphisms (SNPs) and Toxicity of Advanced Non-Small-Cell Lung Cancer Patients Treated with Chemotherapy.
- Published in:
- PLoS ONE, 2012, v. 7, n. 10, p. 1, doi. 10.1371/journal.pone.0048350
- By:
- Publication type:
- Article
Epidemiological study of HER-2 mutations among EGFR wild-type lung adenocarcinoma patients in China.
- Published in:
- BMC Cancer, 2016, v. 16, p. 1, doi. 10.1186/s12885-016-2875-z
- By:
- Publication type:
- Article
SIRPG expression positively associates with an inflamed tumor microenvironment and response to PD-1 blockade.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 8, p. 1, doi. 10.1007/s00262-024-03737-y
- By:
- Publication type:
- Article
Camrelizumab plus famitinib in previously chemo-immunotherapy treated patients with advanced NSCLC: results from an open-label multicenter phase 2 basket study.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 7, p. 1, doi. 10.1007/s00262-024-03715-4
- By:
- Publication type:
- Article
ICI plus chemotherapy prolonged survival over ICI alone in patients with previously treated advanced NSCLC.
- Published in:
- Cancer Immunology, Immunotherapy, 2022, v. 71, n. 1, p. 219, doi. 10.1007/s00262-021-02974-9
- By:
- Publication type:
- Article
Pretreatment neutrophil-to-lymphocyte ratio is associated with outcome of advanced-stage cancer patients treated with immunotherapy: a meta-analysis.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 5, p. 713, doi. 10.1007/s00262-018-2126-z
- By:
- Publication type:
- Article
Neuroendocrine subtypes of small cell lung cancer differ in terms of immune microenvironment and checkpoint molecule distribution.
- Published in:
- Molecular Oncology, 2020, v. 14, n. 9, p. 1947, doi. 10.1002/1878-0261.12741
- By:
- Publication type:
- Article
Clinical features and therapeutic options in non‐small cell lung cancer patients with concomitant mutations of EGFR, ALK, ROS1, KRAS or BRAF.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 6, p. 2858, doi. 10.1002/cam4.2183
- By:
- Publication type:
- Article
Pan‐cancer analysis identifies TERT alterations as predictive biomarkers for immune checkpoint inhibitors treatment.
- Published in:
- Clinical & Translational Medicine, 2020, v. 10, n. 2, p. 1, doi. 10.1002/ctm2.109
- By:
- Publication type:
- Article
Peripheral Blood Autoantibodies Against to Tumor-Associated Antigen Predict Clinical Outcome to Immune Checkpoint Inhibitor-Based Treatment in Advanced Non-Small Cell Lung Cancer.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.625578
- By:
- Publication type:
- Article
Patients With Short PFS to EGFR-TKIs Predicted Better Response to Subsequent Anti-PD-1/PD-L1 Based Immunotherapy in EGFR Common Mutation NSCLC.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.639947
- By:
- Publication type:
- Article
KEYNOTE‐033: Randomized phase 3 study of pembrolizumab vs docetaxel in previously treated, PD‐L1‐positive, advanced NSCLC.
- Published in:
- International Journal of Cancer, 2023, v. 153, n. 3, p. 623, doi. 10.1002/ijc.34532
- By:
- Publication type:
- Article
Special issue "The advance of solid tumor research in China": FGFR4 alterations predict efficacy of immune checkpoint inhibitors in nonsmall cell lung cancer.
- Published in:
- International Journal of Cancer, 2023, v. 152, n. 1, p. 79, doi. 10.1002/ijc.34239
- By:
- Publication type:
- Article
Exosomes transmit T790M mutation‐induced resistance in EGFR‐mutant NSCLC by activating PI3K/AKT signalling pathway.
- Published in:
- Journal of Cellular & Molecular Medicine, 2020, v. 24, n. 2, p. 1529, doi. 10.1111/jcmm.14838
- By:
- Publication type:
- Article
Case Report: Abscopal Effect of Microwave Ablation in a Patient With Advanced Squamous NSCLC and Resistance to Immunotherapy.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.696749
- By:
- Publication type:
- Article
Predictive Effects of ERCC1 and XRCC3 SNP on Efficacy of Platinum-based Chemotherapy in Advanced NSCLC Patients.
- Published in:
- Japanese Journal of Clinical Oncology, 2010, v. 40, n. 10, p. 954, doi. 10.1093/jjco/hyq071
- By:
- Publication type:
- Article
Efficacy and safety of local ablative therapy for patients with NSCLC and coexisting interstitial lung disease.
- Published in:
- Thoracic Cancer, 2024, v. 15, n. 10, p. 778, doi. 10.1111/1759-7714.15258
- By:
- Publication type:
- Article
Re‐biopsy and liquid biopsy for patients with non‐small cell lung cancer after EGFR‐tyrosine kinase inhibitor failure.
- Published in:
- Thoracic Cancer, 2019, v. 10, n. 4, p. 957, doi. 10.1111/1759-7714.13035
- By:
- Publication type:
- Article
Larger tumors are associated with inferior progression‐free survival of first‐line EGFR‐tyrosine kinase inhibitors and a lower abundance of EGFR mutation in patients with advanced non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2019, v. 10, n. 4, p. 686, doi. 10.1111/1759-7714.12986
- By:
- Publication type:
- Article
Effect of transplanted adipose-derived stem cells in mice exhibiting idiopathic pulmonary fibrosis.
- Published in:
- Molecular Medicine Reports, 2015, v. 12, n. 4, p. 5933, doi. 10.3892/mmr.2015.4178
- By:
- Publication type:
- Article